
Morocco Gets New Infectious Disease Surveillance Boost
A one-year, US-backed project will expand laboratory networks, wastewater monitoring and rapid response teams in Morocco.
In the world, COVID-19 news means tracking ongoing variants, vaccine booster recommendations, long COVID research and changes to public health policy. Coverage here follows the evolving data and the guidance that responds to it.

A one-year, US-backed project will expand laboratory networks, wastewater monitoring and rapid response teams in Morocco.
November 11, 2026
Fast-Spreading Covid Variant PJ.2.1 Gains GroundCovid-19 cases linked to the PJ.2.1 variant are rising, with detections now reported on several continents.
November 6, 2026
COVID-19 Vaccines Return Up to $809 Per DollarA 173-country study finds early vaccine access drove the largest health and economic gains.
November 5, 2026
AI-Designed Bird Flu Vaccine Shows Broad Animal ProtectionEarly animal tests suggest one vaccine may guard against many bird flu variants, though human testing has not yet begun.
November 5, 2026
Covid-19 Vaccines Returned Trillions, Study FindsModelled estimates range from $6.43 trillion to $64.3 trillion depending on the valuation method used.
November 5, 2026
Hantavirus Entry Point Mapped in New StudyResearchers identify how the virus attaches to human cells, a step toward antivirals that do not yet exist.
November 4, 2026
Lyme Vaccine Filings Advance in Europe, CanadaAdults in tick-endemic areas may eventually have a new prevention option, though no approval timeline has been set.
November 4, 2026
Swiss Waive Medical Bills for Injured Italian VictimsItalian families of injured Crans-Montana fire victims will not be charged for hospital care in Switzerland.
November 4, 2026
Sanofi Vaccine Messaging Commitments Become BindingOlder adults in Germany and France will see flu vaccine promotions that reference national recommendations through March 2030.
November 2, 2026
WHO Funding Shift Could Steady Emergency ResponseCountries that depend on WHO emergency programs may see funding decisions shape how quickly outbreaks are met.
November 2, 2026
Hepatitis Progress Too Slow, Deaths PersistFewer than five percent of people with chronic hepatitis B are receiving treatment, despite effective vaccines and cures.
Regular subjects here include clinical findings on viral spread, vaccine efficacy, recovery data and institutional policy shifts. Global reporting spans every region and institution involved in the management of pandemic-related health. Vaccine access and the timing of booster cycles often dictate how different jurisdictions manage seasonal infection surges. Research into the lingering effects of the virus and the development of new therapeutics remain the most consistent drivers of public interest.